Beginning of dialog window. Escape will cancel and close the window.
End of dialog window.
Beijing, March 29, 2025 — AstraZeneca CEO Pascal Soriot has commended the Chinese government for its exceptional support and guidance to the pharmaceutical giant, highlighting a level of backing that is uncommon in other countries.
Speaking to CGTN at the China Development Forum 2025 in Beijing on Sunday, Soriot expressed gratitude for the warm welcome AstraZeneca has received in China. “China has been very welcoming of companies that want to give back to society and contribute to China’s economic growth and public health,” he said.
Soriot emphasized that the company’s success in China is largely attributed to the strong partnership with the Chinese government, which has provided unwavering support for AstraZeneca’s initiatives. “The support and guidance we’ve received here is tremendous,” he noted. “It’s a level of support that is not always seen in other countries.”
He also acknowledged China’s commitment to fostering an environment conducive to innovation and collaboration. “Being able to operate in such a supportive ecosystem allows us to focus on what we do best — developing and delivering life-changing medicines to patients,” Soriot added.
AstraZeneca has been actively expanding its presence in China, investing in research and development, and partnering with local companies to enhance healthcare outcomes. The company’s positive experience underscores China’s appeal as a destination for global businesses seeking growth and meaningful impact.
